Client News

DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update

FDA Grants Approval for Stelara®1 Biosimilar FYB202/OtulfiTM2 (ustekinumab-aauz)

Formycon and Fresenius Kabi Receive European Commission Approval for FYB202/Otulfi® (ustekinumab) for the Treatment of Serious Inflammatory Diseases

Affluent Medical – H1 2024 RESULTS: Major Advances in All Three Programs, Several Strategic Agreements Signed, Extension of Financial Runway to July 2025

Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024

Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse Model

SLEEVER® and CARBIOS Globally Launch World’s First Home Compost Biodegradable Tamper Evident Seal: SEELCAP® ONEGO

InflaRx Presents Post Hoc Analysis of SHINE Trial of Vilobelimab in Hidradenitis Suppurativa at the 2024 European Academy of Dermatology and Venereology Congress

Medigene AG Expands Protection of its KRAS Library with Filing of New Patent Application Supporting MDG2021

CARBIOS and Selenis Announce Strategic Partnership to Produce PETG Issued from CARBIOS’ Biorecycling Technology for Cosmetic and Healthcare Markets